Prosthetics

Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis

Retrieved on: 
Monday, September 6, 2021
Surgery, Health, Medical Devices, Medical specialties, Surgery, Musculoskeletal system, Prosthetics, Joints, Meniscus, Knee replacement, Cartilage, Orthopedic surgery, Osteoarthritis, Knee, Arthroscopy, the NUsurface® Meniscus Prosthesis, Active Implants, LLC, Geistlich Pharma AG, MEFISTO, THE NUSURFACE® MENISCUS PROSTHESIS, ACTIVE IMPLANTS, LLC, GEISTLICH PHARMA AG, MEFISTO

Active Implants LLC , a company that develops orthopedic implant solutions, today announced that it has reached an exclusive agreement with Geistlich Pharma AG to be the exclusive Swiss distributor of the companys NUsurface Meniscus Prothesis.

Key Points: 
  • Active Implants LLC , a company that develops orthopedic implant solutions, today announced that it has reached an exclusive agreement with Geistlich Pharma AG to be the exclusive Swiss distributor of the companys NUsurface Meniscus Prothesis.
  • The relationship between Active Implants and Geistlich Pharma began in 2019 with the launch of the MEFISTO project.
  • The NUsurface is the first artificial meniscus to be marketed in Europe and is currently under review by the U.S. Food and Drug Administration (FDA).
  • Geistlich Pharma AG is a Swiss company, owned by the family Geistlich with its headquarters in Central Switzerland in Wolhusen and in Root.

HSS Interactive Case Lecture Highlights Practical Solutions In Shoulder Arthroplasty For Substantial Glenoid Bone Loss

Retrieved on: 
Friday, September 3, 2021
Surgery, Medical specialties, Medicine, Prosthetics, Hospital for Special Surgery, Orthopedic surgery, Reverse shoulder replacement, Arthroplasty, Knee replacement, Bone grafting, Shoulder, Glenoid fossa

The glenoid is the socket part of the shoulder joint that connects to the ball of the upper arm bone.

Key Points: 
  • The glenoid is the socket part of the shoulder joint that connects to the ball of the upper arm bone.
  • Glenoid bone loss can occur due to severe arthritis, traumatic injury or repetitive overuse in sports like baseball or swimming.
  • Symptoms associated with glenoid bone loss include inflammation, pain and decreased shoulder function.
  • Surgical approaches presented included two bone grafting techniques: bony increased offset-total shoulder arthroplasty (BIO-TSA) and bony increased offset-reverse shoulder arthroplasty (BIO-RSA).

Corvion appoints William Cohn, MD and Sean Morris to Board of Directors

Retrieved on: 
Wednesday, August 4, 2021
Prosthetics, Tissue engineering, Biomedical engineering, Implant

WEBSTER, Texas, Aug. 4, 2021 /PRNewswire/ -- Corvion developer of fully implanted mechanical circulatory support devices announced today that William Cohn, MD and Sean Morris have been appointed to the company's Board of Directors, effective immediately.

Key Points: 
  • WEBSTER, Texas, Aug. 4, 2021 /PRNewswire/ -- Corvion developer of fully implanted mechanical circulatory support devices announced today that William Cohn, MD and Sean Morris have been appointed to the company's Board of Directors, effective immediately.
  • "We are delighted to welcome Dr. Cohn and Sean to our Board.
  • I look forward to helping Greg and his team make big strides during this very exciting time," said Mr. Morris.
  • Corvion ( www.corvion.com ) is a pre-clinical stage medical device company focused on bringing fully implanted heart assist technology to the worldwide market for mechanical circulatory support.

Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System

Retrieved on: 
Tuesday, August 3, 2021
Prosthetics, Medicine, Spine, Implant, Minimally invasive procedure, Forward-looking statement, Health sciences, Life sciences

Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, "This approval is the first of its kind in the world by offering an implant based upon a patient's bone density.

Key Points: 
  • Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, "This approval is the first of its kind in the world by offering an implant based upon a patient's bone density.
  • Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
  • Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release.
  • These statements speak only as of the date of this press release, and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Global Knee Replacement Market Report 2021-2027: Leading Players are Smith & Nephew, Stryker, J&J, Zimmer Biomet, B. Braun Melsungen, MicroPort Scientific, Integra Life Sciences, Conformis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021
Surgery, Health, Prosthetics, Medicine, Clinical medicine, Kosciusko County, Indiana, Economy of Indiana, Knee replacement, Unicompartmental knee arthroplasty, Biomet, Knee, ROSA, Zimmer Biomet Robotics

The "Knee Replacement Market Global Forecast Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Knee Replacement Market Global Forecast Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Knee replacement is a surgical procedure that minimizes pain and enhances the quality of life in patients with severe arthritis.
  • Developed countries, such as the United States and Germany, have a significant market share in the knee replacement business worldwide.
  • In 2021, Zimmer Biomet Holdings, Inc., announced the ROSA Partial Knee System for robotically-assisted partial knee replacement surgeries.

SI-BONE, Inc. Announces Anthem, Inc. Adopts Coverage Guidelines for Sacroiliac Joint Fusion Exclusive to the Triangular iFuse Implant System® for Its More Than 40 Million Members

Retrieved on: 
Monday, August 2, 2021
Prosthetics, Anatomy, Pelvis, Medical specialties, Medical technology, Biomedical engineering, Implant, Tissue engineering, Sacroiliac joint

Anthem has adopted coverage guidelines from AIM Specialty Health, a subsidiary specialty benefit management company with medical necessity guidelines that support minimally invasive SI joint fusion only when iFuse implants (titanium triangular implants) are used.

Key Points: 
  • Anthem has adopted coverage guidelines from AIM Specialty Health, a subsidiary specialty benefit management company with medical necessity guidelines that support minimally invasive SI joint fusion only when iFuse implants (titanium triangular implants) are used.
  • The new policy provides coverage for chronic sacroiliac joint pain and functional impairment, provided certain criteria are met, resulting in virtually universal coverage for the iFuse Implant System.
  • Since then, more than 2,400 surgeons have performed a combined total of more than 55,000 SI joint fusion procedures.
  • SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. 2021 SI-BONE, Inc. All Rights Reserved.

New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty

Retrieved on: 
Thursday, July 29, 2021
Medical specialties, Clinical medicine, Medicine, Acute pain, Prosthetics, Knee replacement, Opioid, Pain management, Arthroplasty, Pain, Manipulation under anesthesia

The results of the study, A Multimodal Pain Management Protocol Including Preoperative Cryoneurolysis for Total Knee Arthroplasty to Reduce Pain, Opioid Consumption, and Length of Stay, were published in Arthroplasty Today .

Key Points: 
  • The results of the study, A Multimodal Pain Management Protocol Including Preoperative Cryoneurolysis for Total Knee Arthroplasty to Reduce Pain, Opioid Consumption, and Length of Stay, were published in Arthroplasty Today .
  • This retrospective analysis utilized data from patients who underwent TKA by a single surgeon at one center.
  • Patients who received iovera before TKA were compared with a historical control group including patients who underwent TKA without iovera.
  • The primary outcome was opioid intake at various time points from hospital stay to 6 weeks after discharge.

Dr. Bruce Smoler, the First and Only in Michigan to Perform Robotic-Assisted Dental Implant Procedures

Retrieved on: 
Thursday, July 29, 2021
Prosthetics, Medical specialties, Dentistry, Health sciences, Oral surgery, Restorative dentistry, Prosthodontology, Dental implant, Implant, Root analogue dental implant, Computer-assisted surgery

This state of the art implant robotic technology ensures highly accurate and desired implant placement.

Key Points: 
  • This state of the art implant robotic technology ensures highly accurate and desired implant placement.
  • Features and benefits of dental implant robotic technology includes:
    Efficient Treatment: New robotic technology allows same day implants.
  • Accuracy: Dr. Bruce Smoler can plan and precisely place patient specific implants to help ensure imperial dental function and a brilliant smile.
  • Robotic-assisted dental implant procedures are now being performed at the Smoler Smiles Westland office.

EQS-News: Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur

Retrieved on: 
Wednesday, July 28, 2021
Musculoskeletal system, Anatomy, Skeletal system, Pelvis, Hip, Femur, Acetabulum, Femoral, Prosthetics, Bone fractures, Hip replacement

Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur

Key Points: 
  • Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur
    Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur
    AMIS(R)-K Long, Iliac Screw Mpact(R) 3D Metal, and 3D Metal(R) B-Cage, after each of the items received CE marking.
  • These new products, alongside the M-Vizion(R) Modular Femoral Revision Stem, further broaden the Medacta Hip Revision Platform.
  • "By further expanding our Hip Revision Platform, we are well-positioned to meet our goal of being a uniquely valuable partner for hip surgeons worldwide.
  • The M-Vizion Femoral Modular Revision System, the core of the Medacta Hip Revision Platform, allows surgeons to feel more confident in the OR when undertaking femoral revision cases.

Electroceuticals/Bioelectric Medicine Markets, 2026 - Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators, Ischemia, Epilepsy, Implantable, Noninvasive - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 28, 2021
General Health, Science, Health, Research, Branches of biology, Medical technology, Biology, Medical devices, Neurotechnology, Biomedical engineering, Prosthetics, Cybernetics, Neuromodulation, Neurostimulation, Implant, Stimulator

The "Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • On the other hand, the high cost of electroceutical devices and the requirement of high capital investments are the major factors hampering the growth of this market.
  • In 2020, the cochlear implants segment accounted for the highest growth rate in the electroceuticals market.
  • The global electroceuticals market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.